They seem to be OK on the cash flow side (for now). Their situation became precarious in 2000 or so when the patent litigation went south on them. But, the court of appeals reversed a key interference finding against them, and they have now finally ended that litigation as part of a complex settlement with NSM.
If the prior rise to 30 was based on expected royalties - whose odds were dashed by the original interference ruling - then once the market realizes that the litigation is resolved and that the business model has returned, it would seem that there could at least be some upside in this one. I must say, however, then I do not know the RMTR story anywhere near as well as the RMBS story, and don't even understand FRAM